Lawsuit filed against Applied Therapeutics, Inc. for Securities Fraud
Investors in Applied Therapeutics Inc. (NASDAQ: APLT) have until February 18 to join the class action lawsuit against the company for securities fraud. The lawsuit alleges that Applied Therapeutics made false or misleading statements about the results of its testing for diabetic cardiomyopathy, a type of heart disease. These alleged misrepresentations caused Applied Therapeutics’ stock price to drop significantly once the truth came to light.
If you purchased Applied Therapeutics stock between November 7, 2019, and September 7, 2020, you may be eligible to participate in the class action lawsuit. It is important to contact BFA Law before the February 18 deadline to ensure you are included in the case.
This situation serves as a reminder for investors to always do their due diligence before investing in any company. Make sure to thoroughly research a company’s claims and financial health before buying stock, and be aware of any pending litigation or investigations that could impact its stock price.
If you believe you have been affected by Applied Therapeutics’ alleged securities fraud, be sure to reach out to BFA Law before the February 18 deadline to protect your rights. Stay informed and make informed decisions when it comes to your investments.
